Potential Cognitive and Hormonal Benefits Beyond sleep and recovery, there are broader wellness benefits that the research around DSIP is starting to touch
Most outcomes were classified as NS, indicating that GLP-1 RAs have no overall effect on cancer risk
GLP-1 (Glukagon Benzeri Peptid-1) agonistleri, balangta Tip 2 diyabet tedavisi iin gelitirilen bir ila snfdr
Key findings from the Phase 2 trial included: Dose-dependent reductions in body weight across all active treatment arms Significant improvements in waist circumference, a key marker of visceral adiposity Reductions in fasting insulin levels and HbA1c Improvements in lipid profiles, including triglycerides Phase 3 trials are currently ongoing and are expected to include larger, more diverse populations with more granular subgroup analyses, including sex-specific data
This is where things get even trickier
retatrutide breakdown for a full clinical comparison